| Cat. No. |
Size |
Price |
Figures |
|---|
RP11102-0.5 mg
| 0.5 mg | $ 61.75 | HPLC: 20050919140132 (PDF)
MASS SPECE: 20050919140154 (PDF)
MSDS: 20080814043324 (PDF)
References:
- Kaneider NC, et al. Involvement of cyclic adenosine monophosphate-dependent protein kinase A and pertussis toxin-sensitive G proteins in the migratory response of human CD14+ mononuclear cells to katacalcin. J. Bone Miner. Res. Oct 2002; 17(10): 1872-1882.
- Angelucci F, et al. A pilot study of rat brain regional distribution of calcitonin, katacalcin and calcitonin gene-related peptide before and after antipsychotic treatment. Neuropeptides. Oct-Dec 2001; 35(5-6): 285-291.
- Oberhoffer M, et al. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content. J. Crit. Care. Mar 1999; 14(1): 29-33.
|
|---|
| Full Name | |
Sequence
(one-letter code) |
DMSSDLERDHRPHVSMPQNAN |
Sequence
(three-letter code) | {ASP}{MET}{SER}{SER}{ASP}{LEU}{GLU}{ARG}{ASP}{HIS}
{ARG}{PRO}{HIS}{VAL}{SER}{MET}{PRO}{GLN}{ASN}{ALA}
{ASN} |
|---|
| Description | Katacalcin is a newly discovered calcium-lowering hormone predicted from the nucleotide sequence of a cloned cDNA derived from human calcitonin mRNA. Katacalcin, which is a human calcitonin precursor peptide, also called C-procalcitonin, katacalcin or PDN-21, flanking calcitonin on the C-terminal side within the human calcitonin precursor, can significantly lower plasma calcium level. |
|---|
| Solubility | Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. |
|---|
| Formula | C97H154N34O36S2 |
|---|
| M.W. | 2436.6 |
|---|
| Cas | 85916-47-8 |
|---|
| Purity | > 95% |
|---|
| Storage | Before using, store the peptide in the DRY form at 0 - 5°C. For best and repeatable results, rehydrate the peptide immediately before using. Do not re-freeze any unused portions. |
| Notes | Katacalcin is a potent plasma calcium-lowering peptide. |
|---|
